BLLN - Company ID 0002070849
BillionToOne, Inc. trades as BLLN and has a market capitalization of $4.51 B, making it the #1499 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $305.11M, up 100.0% from the prior year and net income of $7.45M. This page tracks BillionToOne, Inc. through 61 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin expanded from -115.3% to 2.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-21 |
| Proxy materials | DEFA14A | 2026-04-21 |
| Proxy statement | DEF 14A | 2026-04-21 |
| Annual report | 10-K | 2026-03-11 |
May 06, 2026 16:05 ET
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests ...
April 15, 2026 08:05 ET | Source: BillionToOne, Inc. BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026. MENLO PARK ...
The largest companies sharing BillionToOne, Inc.'s SEC industry classification (services-medical laboratories).
BillionToOne, Inc. (BLLN) has a market capitalization of $4.51 B as of 2026-05-29, ranking #1499 among US-listed companies.
BillionToOne, Inc. reported revenue of $305.11M for fiscal year 2025, an increase of 100.0% year over year.
Yes. BillionToOne, Inc. reported net income of $7.45M in its latest fiscal year.